Genitourinary Cancers

domain

Cancers of the urinary and male reproductive systems, including prostate, bladder, kidney, and testicular cancers.

104

Centers

10,807

Active Trials

505

NIH Grants

$26.2B

NCI Funding

General Cancer Types(383)

NameCenters
Renal Cell Carcinoma90
Clear Cell Renal Cell Carcinoma89
Metastatic Renal Cell Carcinoma87
Recurrent Prostate Carcinoma85
Prostate Adenocarcinoma83
Bladder Carcinoma82
Prostate Carcinoma82
Metastatic Urothelial Carcinoma79
Kidney Carcinoma77
Metastatic Prostate Carcinoma75
Adrenal Gland Pheochromocytoma74
Castration-Resistant Prostate Carcinoma73
Stage III Prostate Cancer AJCC v873
Muscle Invasive Bladder Urothelial Carcinoma71
Locally Advanced Urothelial Carcinoma70
Papillary Renal Cell Carcinoma68
Kidney Medullary Carcinoma67
Unresectable Urothelial Carcinoma67
Adrenal Cortical Carcinoma66
Bladder Adenocarcinoma66
Bladder Urothelial Carcinoma64
Stage IV Bladder Cancer AJCC v863
Stage IV Prostate Cancer AJCC v863
Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma58
Stage II Renal Pelvis and Ureter Cancer AJCC v758
Stage III Renal Pelvis and Ureter Cancer AJCC v758
Urethral Adenocarcinoma52
Stage III Bladder Cancer AJCC v851
Advanced Renal Cell Carcinoma50
Metastatic Prostate Adenocarcinoma48
Chromophobe Renal Cell Carcinoma45
Metastatic Urethral Carcinoma41
Bladder Squamous Cell Carcinoma39
Stage I Bladder Cancer AJCC v6 and v739
Invasive Bladder Plasmacytoid Urothelial Carcinoma38
Invasive Bladder Sarcomatoid Urothelial Carcinoma38
Bladder Neuroendocrine Carcinoma37
Invasive Bladder Giant Cell Urothelial Carcinoma37
Invasive Bladder Nested Urothelial Carcinoma37
Invasive Bladder Urothelial Carcinoma37
Stage II Prostate Cancer AJCC v837
Renal Pelvis and Ureter Urothelial Carcinoma35
Stage IV Renal Pelvis and Ureter Cancer AJCC v833
Refractory Urothelial Carcinoma32
Stage II Prostate Cancer AJCC v732
Bladder Flat Urothelial Carcinoma In Situ29
Castration-Sensitive Prostate Carcinoma29
Prostate Cancer Patients28
Prostatectomy27
Prostate Cancer (CRPC)25
Ureter Carcinoma24
Metastatic Renal Pelvis and Ureter Urothelial Carcinoma22
Radical Prostatectomy19
Chronic Kidney Disease14
Bladder Tumor10
Bladder Tumors10
Refractory Prostate Carcinoma10
Malignant Genitourinary System Neoplasm9
Acute Kidney Injury8
Advanced Bladder Carcinoma8
Advanced Genitourinary System Carcinoma7
Metastatic Genitourinary System Carcinoma7
Penile Carcinoma7
Prostate Specific Antigen7
Stage III Penile Cancer AJCC v87
Urinary Tract Carcinoma7
Advanced Prostate Carcinoma6
Bladder Neoplasm6
Castration Resistant Prostate Adenocarcinoma6
Advanced Bladder Cancer5
Localized Prostate Carcinoma5
Renal Tumor5
URINARY BLADDER5
Advanced Penile Carcinoma4
Chronic Kidney Diseases4
Renal Carcinoma4
Renal Mass4
Renal Pelvis Urothelial Carcinoma4
Renal Tumors4
Adrenal Tumors3
Cancer of the Urinary Tract3
Castration Sensitive Prostate Cancer3
End-stage Renal Disease3
Genito Urinary Cancer3
Locally Advanced Prostate Carcinoma3
Low Risk Prostate Cancer3
Neoplasm, Prostate3
Non-Muscle Invasive Bladder Carcinoma3
Oligometastatic Prostate Cancer3
Prostate Cancer Prevention3
Renal Toxicity3
Stage III Adrenocortical Carcinoma3
Stage IV Adrenocortical Carcinoma3
Urethral Cancer Associated With Invasive Bladder Cancer3
Advanced and Metastatic Urothelial Cancer2
Bladder (Urothelial, Transitional Cell) Cancer2
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable2
Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)2
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)2
Bladder Cancer TNM Staging Distant Metastasis (M) M02
Bladder Cancer TNM Staging Primary Tumor (T) T22
Bladder Cancer TNM Staging Primary Tumor (T) T2A2
Bladder Cancer TNM Staging Primary Tumor (T) T2B2
Bladder Cancer TNM Staging Primary Tumor (T) T32
Bladder Cancer TNM Staging Primary Tumor (T) T3A2
Bladder Cancer TNM Staging Primary Tumor (T) T3B2
Bladder Cancer TNM Staging Regional Lymph Node (N) N02
Bladder Cancer TNM Staging Regional Lymph Node (N) N12
Bladder Disease2
Bladder Tumor (TURBT)2
Cancer of the Bladder2
Carcinoma in Situ of Bladder2
Castrate Sensitive Prostate Cancer2
Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents2
Clear Cell Renal Cell Cancer (ccRCC)2
Collecting Duct Renal Cell Carcinoma2
Erectile Dysfunction Following Radical Prostatectomy2
Genitourinary System Carcinoma2
High Risk Biochemical Recurrence of Non-metastatic Castration-sensitive Prostate Cancer2
Invasive Urothelial Carcinoma2
Kidney Tumor2
Localized Muscle Invasive Bladder Urothelial Carcinoma2
Locally Advanced Prostate Cancer2
Malignant Neoplasm of Bladder2
Malignant Neoplasm of Prostate2
Metastatic Kidney Cancer2
Metastatic Urothelial Carcinoma & Renal Pelvis & Ureter2
Monoclonal Gammopathy of Renal Significance2
Muscle-invasive Urothelial Cancer of the Bladder2
Neoplasm, Bladder2
Neoplasm, Urinary Bladder2
Neoplasms of the Prostate2
Non-metastatic Castration-sensitive Prostate Cancer2
Nuclear Protein in Testis (NUT) Carcinoma2
Post Prostatectomy2
Prostate CA2
Prostate Cancer Stage III2
Prostate Carcinoma Metastatic in the Soft Tissue2
Prostate Disease2
Prostate Small Cell Carcinoma2
Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter2
Renal Cell Carcinoma, Metastatic2
Renal Insufficiency2
Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v72
Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v82
Stage III Adrenal Cortex Carcinoma2
Stage IVA Bladder Cancer2
Stage IVB Bladder Cancer2
Testicular Neoplasms2
Translocation Renal Cell Carcinoma2
Unresectable Bladder Carcinoma2
Upper Tract Urothelial Carcinoma2
Urinary Tract Cancers2
Adenocarcinoma of the Bladder1
Adenocarcinoma, Prostate1
Adrenal Cancer1
Adrenal Cortical Cancer1
Adrenal Gland Tumors1
Adrenal Malignancies1
Adrenal Metastases1
Adrenocortical Cancer1
Adrenocortical Tumor1
Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma1
Advanced Prostate Adenocarcinoma1
Advanced Renal Cell Carcinoma (aRCC)1
Advanced Urethral Carcinoma1
BCG-Unresponsive Bladder Cancer1
Bladder Cancer Stage 01
Bladder Cancer Stage I1
Bladder Cancer Stage II1
Bladder Cancer Stage III1
Bladder Cancer Stage IV1
Bladder Papillary Urothelial Carcinoma1
Bone-Metastatic, Castration-Resistant Prostate Cancer1
Cancer of Bladder1
Cancer of Kidney1
Carcinoma of Prostate1
Castration-resistant Prostate Cancer Patients with Oligometastases1
Cellular Diagnosis, Prostate Cancer1
Chronic Renal Failure1
Elevated Prostate Specific Antigen (PSA)1
ENSAT Stage I Adrenal Cortex Carcinoma1
ENSAT Stage II Adrenal Cortex Carcinoma1
ENSAT Stage III Adrenal Cortex Carcinoma1
Erectile Dysfunction Following Simple Prostatectomy1
Familial Testicular Germ Cell Tumor1
Fumarate Hydratase Deficient Renal Cell Carcinoma1
Genito-urinary1
Genitourinary Neoplasms Malignancy and Gender Unspecified1
Hereditary Clear Cell Renal Cell Carcinoma1
High Risk Urothelial Carcinoma of the Upper Urinary Tracts1
High-grade Bladder Urothelial Dysplasia/Carcinoma in Situ1
Human Papillomavirus Positive Penile Carcinoma1
Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant1
Infiltrating Bladder Urothelial Carcinoma With Giant Cells1
Infiltrating Bladder Urothelial Carcinoma With Glandular Differentiation1
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation1
Infiltrating Bladder Urothelial Carcinoma With Trophoblastic Differentiation1
Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant1
Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant1
Infiltrating Bladder Urothelial Carcinoma, Nested Variant1
Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant1
Intermediate Risk Prostate Cancer1
Localized Prostate Adenocarcinoma1
Locally Advanced Adrenal Cortex Carcinoma1
Locally Advanced Bladder Carcinoma1
Locally Advanced or Metastatic Renal Cell Carcinoma1
Locally Advanced or Metastatic Urothelial Carcinoma1
Locally Advanced Renal Cell Carcinoma1
Low and Intermediate Risk Prostate Cancer1
Malignant Adrenal Gland Neoplasm1
Malignant Neoplasms of Urinary Tract1
Malignant Renal Pelvis Neoplasm1
Malignant Testicular Germ Cell Tumor1
Malignant Tumor of the Urinary Bladder1
Malignant Tumor of Urinary Bladder1
Malignant Ureter Neoplasm1
Malignant Urethral Neoplasm1
Malignant Urinary System Neoplasm1
Metastatic Adrenocortical Carcinoma1
Metastatic Castration-resistant Prostate Cancer (CRPC)1
Metastatic Castration-resistant Prostate Cancer and Other Solid Tumors1
Metastatic Malignant Neoplasm in the Prostate Gland1
Metastatic Ncc Renal Cell Carcinoma1
Metastatic Renal Cancer1
Metastatic Urothelial Carcinoma (UC)1
Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter1
Neoplasms, Bladder1
Neoplasms, Kidney1
Neuroendocrine Carcinoma of Prostate1
Node; Prostate1
Non-Clear Cell Renal Cell Carcinoma1
Non-Invasive Bladder Urothelial Carcinoma1
Non-Metastatic Prostate Carcinoma1
Non-metastatic, Hormone naïve Prostate Cancer1
Non-Muscle-Invasive Urothelial Carcinoma1
Non-Transitional Cell Carcinoma of the Urothelial Tract1
Nonmuscle Invasive Bladder Cancer1
Papillary Carcinoma of Bladder (Diagnosis)1
Post-Operative Prostate Cancer1
Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation1
Prostate Cancer (Diagnosis)1
Prostate Cancer (Post Prostatectomy)1
Prostate Cancer Castration-resistant Prostate Cancer1
Prostate Cancer Patients Undergoing Radical Prostatectomy1
Prostate Cancer Stage I AJCC V61
Prostate Cancer Stage II1
Prostate Cancer Stage IV1
Prostate Neuroendocrine Neoplasm1
Prostate-specific Membrane Antigen Positive Tumors1
Recurrent Prostate Adenocarcinoma1
Recurrent Prostate Cancer After Surgery1
Renal Cell Carcinoma Stage IV1
Rhabdoid Tumor of the Kidney (RTK)1
Secondary Malignant Neoplasm of Prostate1
Small Cell of the Bladder1
Small Renal Mass1
Stage 0a Bladder Urothelial Carcinoma1
Stage 0is Renal Pelvis and Ureter Cancer AJCC v81
Stage 1 Bladder Cancer AJCC v81
Stage I Bladder Cancer1
Stage I Bladder Cancer With Carcinoma In Situ1
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v71
Stage II Kidney Cancer1
Stage II Prostate Carcinoma1
Stage III Bladder Cancer American Joint Committee on Cancer ( AJCC) v81
Stage III Kidney Cancer1
Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v81
Stage IV Adrenal Cortex Carcinoma AJCC v81
Stage IV Kidney Cancer1
Stage IV Prostate Adenocarcinoma Cancer AJCC v81
Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v81
Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v81
Stage IVB Prostate Cancer American Joint Committee on Cancer v81
Succinate Dehydrogenase Deficient Renal Cell Carcinoma1
Testicular Choriocarcinoma and Embryonal Carcinoma1
Testicular Choriocarcinoma and Seminoma1
Testicular Choriocarcinoma and Teratoma1
Testicular Embryonal Carcinoma and Seminoma1
Testicular Embryonal Carcinoma and Teratoma1
Testicular Embryonal Carcinoma and Teratoma With Seminoma1
Testicular Embryonal Carcinoma and Yolk Sac Tumor1
Testicular Embryonal Carcinoma and Yolk Sac Tumor With Seminoma1
Testicular Immature Teratoma1
Testicular Mature Teratoma1
Testicular Teratoma1
Testicular Tumor1
Testicular Yolk Sac Tumor and Teratoma1
Testicular Yolk Sac Tumor and Teratoma With Seminoma1
Transitional Cell Cancer of Renal Pelvis and Ureter1
Unresectable Adrenal Cortex Carcinoma1
Unresectable Advanced Renal Cell Carcinoma1
Ureter Small Cell Carcinoma1
Urethral Carcinoma1
Urinary Cancer1
Urinary Complication1
Urinary System Disorder1
Urinary System Neoplasm1
Urothelial Carcinoma, HCC1
Adrenal Cortical Carcinoma by AJCC v7 Stage—
Adrenal Cortical Carcinoma by AJCC v8 Stage—
Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma by AJCC v8 Stage—
Adrenal Medulla Neoplasm—
Advanced Kidney Carcinoma—
Advanced Renal Pelvis and Ureter Urothelial Carcinoma—
Advanced Urinary System Carcinoma—
Adverse Event Associated with the Kidney and Genitourinary System—
Benign Prostate Neoplasm—
Benign Urinary System Neoplasm—
Bladder Cancer by AJCC v6 Stage—
Bladder Cancer by AJCC v8 Stage—
Bladder Disorder—
Bladder Flat Urothelial Carcinoma—
Bladder Large Cell Neuroendocrine Carcinoma—
Bladder Neuroendocrine Neoplasm—
Bladder Non-Urothelial Carcinoma—
Bladder Papillary Urothelial Neoplasm—
Bladder Urothelial Carcinoma In Situ—
Castration-Sensitive Prostate Adenocarcinoma—
Congenital Urinary System Abnormality—
Early Stage Bladder Urothelial Carcinoma—
Genitourinary Signs and Symptoms—
Genitourinary System Neoplasm—
Human Papillomavirus-Independent Penile Squamous Cell Carcinoma—
Invasive Adenocarcinoma of the Mouse Prostate Gland—
Invasive Bladder Carcinoma—
Invasive Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma—
Invasive Bladder Lipid-Rich Urothelial Carcinoma—
Invasive Bladder Micropapillary Urothelial Carcinoma—
Invasive Renal Pelvis and Ureter Urothelial Carcinoma—
Kidney Adenoma—
Kidney and Ureter Neoplasm—
Kidney Carcinoma Molecular Subtypes—
Locally Advanced Unresectable Urinary System Carcinoma—
Locally Advanced Urethral Carcinoma—
Malignant Bladder Neoplasm—
Malignant Kidney Neoplasm—
Malignant Mouse Bladder Neoplasm—
Malignant Testicular Non-Seminomatous Germ Cell Tumor—
Malignant Urinary Tract Neoplasm—
Metastatic Urinary System Carcinoma—
Mouse Adrenal Gland Neoplasms—
Mouse Bladder Carcinoma—
Mouse Urinary Tract Neoplasm—
National Comprehensive Cancer Network Prostate Cancer Risk Stratification for Clinically Localized Disease—
NCI CTEP SDC Kidney Neoplasm Category Terminology—
Penile Cancer by AJCC v8 Stage—
Prostate Acinar Adenocarcinoma—
Prostate Adenocarcinoma by AJCC v7 Stage—
Prostate Cancer by AJCC v8 Stage—
Prostate Cancer by Whitmore-Jewett Stage—
Prostate Neuroendocrine Carcinoma—
Prostatic Urethra Cancer Pathologic Primary Tumor TNM Finding v8—
Rat Urinary System Neoplasms—
Rat Urinary System Part—
Recurrent Kidney Carcinoma—
Recurrent Renal Pelvis and Ureter Urothelial Carcinoma—
Recurrent Urethral Carcinoma—
Recurrent Urinary System Carcinoma—
Refractory Urinary System Carcinoma—
Renal and Urinary Disorders, CTCAE 5.0—
Renal Cell Cancer by AJCC v6 Stage—
Renal Cell Cancer by AJCC v7 Stage—
Renal Cell Cancer by AJCC v8 Stage—
Renal Cell Carcinoma with MiT Translocations—
Renal Pelvis and Ureter Cancer by AJCC v7 Stage—
Renal Pelvis and Ureter Cancer by AJCC v8 Stage—
Renal Pelvis and Ureter Carcinoma—
Renal Pelvis Cancer by AJCC v8 Stage—
Stage I Testicular Cancer AJCC v6 and v7—
Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7—
Stage II Testicular Cancer AJCC v6 and v7—
Stage II Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7—
Stage III Testicular Cancer AJCC v6 and v7—
Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7—
Testicular Cancer by AJCC v8 Stage—
Testicular Failure—
Unresectable Renal Pelvis and Ureter Urothelial Carcinoma—
Urethral Cancer by AJCC v7 Stage—
Urethral Cancer by AJCC v8 Stage—
Urinary System Finding—
Urinary System Precancerous Condition—
Urinary Tract Stenosis—

Top Centers for Genitourinary Cancers(104)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Northwell Health Cancer InstituteNew York, NY
—
2
Wilmot Cancer Institute, UR MedicineRochester, NY
NCI Clinical
—
3
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
—
4
UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA
NCI Comprehensive
—
5
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
—
6
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
—
7
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
—
8
Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA
NCI Comprehensive
—
9
University of Michigan Rogel Cancer CenterAnn Arbor, MI
NCI Comprehensive
—
10
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
—
11
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
—
12
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
NCI Comprehensive
—
13
UPMC Hillman Cancer CenterPittsburgh, PA
NCI Comprehensive
—
14
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
—
15
Yale Cancer Center Yale School of MedicineNew Haven, CT
NCI Comprehensive
—
16
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityChicago, IL
NCI Comprehensive
—
17
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
—
18
Herbert Irving Comprehensive Cancer CenterNew York, NY
NCI Comprehensive
—
19
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
—
20
Mount Sinai Tisch Cancer CenterNew York, NY
NCI Comprehensive
—
21
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
—
22
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
—
23
UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
24
Duke Cancer InstituteDurham, NC
NCI Comprehensive
—
25
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
—
26
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
—
27
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
—
28
Sandra and Edward Meyer Cancer Center at Weill Cornell MedicineNew York, NY
—
29
Winship Cancer InstituteAtlanta, GA
NCI Comprehensive
—
30
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
—
31
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
—
32
University of Wisconsin Carbone Cancer CenterMadison, WI
NCI Comprehensive
—
33
OHSU Knight Cancer InstitutePortland, OR
NCI Comprehensive
—
34
City of Hope Comprehensive Cancer CenterDuarte, CA
NCI Comprehensive
—
35
USC Norris Comprehensive Cancer CenterLos Angeles, CA
NCI Comprehensive
—
36
Comprehensive Cancer Center St. Jude Children’s Research HospitalMemphis, TN
NCI Comprehensive
—
37
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
—
38
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
—
39
O’Neal Comprehensive Cancer Center at the University of Alabama at BirminghamBirmingham, AL
NCI Comprehensive
—
40
Huntsman Cancer Institute at the University of UtahSalt Lake City, UT
NCI Comprehensive
—
41
Case Comprehensive Cancer CenterCleveland, OH
NCI Comprehensive
—
42
UF Health Cancer InstituteGainesville, FL
NCI Clinical
—
43
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
—
44
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
—
45
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
—
46
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
—
47
Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN
NCI Comprehensive
—
48
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
—
49
Hollings Cancer CenterCharleston, SC
NCI Clinical
—
50
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
—
51
UCI Chao Family Comprehensive Cancer CenterOrange, CA
NCI Comprehensive
—
52
Medical College of Wisconsin Cancer CenterMilwaukee, WI
—
53
Cedars-Sinai CancerLos Angeles, CA
—
54
VCU Massey Comprehensive Cancer CenterRichmond, VA
NCI Comprehensive
—
55
UK Markey Cancer CenterLexington, KY
NCI Comprehensive
—
56
UMass Memorial Health Cancer CenterWorcester, MA
—
57
Cleveland Clinic Cancer CenterCleveland, OH
—
58
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
—
59
Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC
NCI Comprehensive
—
60
Georgetown Lombardi Comprehensive Cancer CenterWashington, DC
NCI Comprehensive
—
61
Koch Institute for Integrative Cancer Research at MITCambridge, MA
NCI Basic_laboratory
—
62
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
—
63
Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA
NCI Comprehensive
—
64
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterBaltimore, MD
NCI Comprehensive
—
65
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
—
66
Ellen and Ronald Caplan Cancer Center of The Wistar InstitutePhiladelphia, PA
NCI Basic_laboratory
—
67
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
—
68
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
—
69
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
—
70
University of Illinois Cancer CenterChicago, IL
—
71
University of Hawai‘i Cancer CenterHonolulu, HI
NCI Clinical
—
72
Sanford Burnham Prebys Medical Discovery InstituteLa Jolla, CA
NCI Basic_laboratory
—
73
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
—
74
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
—
75
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
—
76
Salk Institute Cancer CenterLa Jolla, CA
NCI Basic_laboratory
—
77
Boston University Cancer CenterBoston, MA
—
78
Karmanos Cancer InstituteDetroit, MI
NCI Comprehensive
—
79
Purdue University Institute for Cancer ResearchWest Lafayette, IN
NCI Basic_laboratory
—
80
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
—
81
Cancer Center at IllinoisUrbana, IL
—
82
Stony Brook Cancer CenterStony Brook, NY
—
83
Penn State Cancer InstituteHershey, PA
—
84
The Jackson Laboratory Cancer CenterBar Harbor, ME
NCI Basic_laboratory
—
85
University of Cincinnati Cancer CenterCincinnati, OH
—
86
Livestrong Cancer InstitutesAustin, TX
—
87
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
—
88
UofL James Graham Brown Cancer CenterLouisville, KY
—
89
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
—
90
Georgia Cancer Center, Augusta UniversityAugusta, GA
—
91
Ellis Fischel Cancer Center, MU Health CareColumbia, MO
—
92
Legorreta Cancer Center at Brown UniversityProvidence, RI
—
93
The University of Vermont Cancer CenterBurlington, VT
—
94
University of Puerto Rico Comprehensive Cancer CenterSan Juan, PR
—
95
Cardinal Bernardin Cancer CenterMaywood, IL
—
96
Upstate Cancer CenterSyracuse, NY
—
97
University of Texas Medical Branch Cancer CenterGalveston, TX
—
98
UMMC Cancer Center and Research InstituteJackson, MS
—
99
Loma Linda University Cancer CenterLoma Linda, CA
—
100
BC CancerVancouver, BC
—
101
Murtha Cancer Center at Walter Reed BethesdaBethesda, MD
—
102
Princess Margaret Cancer CentreToronto, ON
—
103
Tampa General Hospital Cancer InstituteTampa, FL
—
104
Louisiana Cancer Research CenterNew Orleans, LA
—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →